Dubois' Lupus Erythematosus and Related Syndromes
Expert Consult - Online and Print
By- Daniel Wallace, MD, FAAP, FACR, Medical Director, Wallace Rheumatic Study Center; Attending Physician, Cedars-Sinai Medical Center; Clinical Professor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
- Bevra Hahn, MD, Professor of Medicine, Chief, Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, California
Recognized for more than 45 years as the definitive text in the field, Dubois Lupus Erythematosus and Related Syndromes strikes the perfect balance between basic science and clinical expertise, providing the evidence-based findings, treatment consensuses, and practical clinical information you need to confidently diagnose and manage SLE.
Hardbound, 712 Pages
Published: October 2012
Imprint: Saunders
ISBN: 978-1-4377-1893-5
Contents
Section I: What is Lupus?
1. Definition and classification of Lupus and Lupus-Related Disorders
2. The Epidemiology of Lupus
Section II: The Pathogenesis of Lupus
3. The Pathogenesis of SLE
4. Genetics of Human SLE5. Epigenetics of Lupus
6. The Innate Immune System in SLE7. Cytokines and Interferons in Lupus
8. The Structure and Derivation of Antibodies and Autoantibodies9. T Cells
10. Regulatory Cells in SLE11. Apoptosis, Necrosis, and Autophagy
12. Abnormalities in Immune Complex Clearance and Fcy Receptor Function13. Neural-Immune Interactions: Principles and Relevance to SLE
14. Complement and SLE15. Mechanisms of Acute Inflammation and Vascular Injury in SLE
16. Mechanisms of Tissue Damage - Free Radicals and Fibrosis17. Animal Models of SLE
18. Pathogenic Mechanisms in Lupus NephritisSection III: Autoantibodies19. Immune Tolerance Defects in Lupus
20. Autoantibodies
21. Autoantigenesis and Entigen-Based Therapy and Vaccination in SLESection IV: Clinical Aspects of SLE22. Overview and Clinical Presentation
23. Pathomechanisms of Cutaneous Lupus Erythematosus
24. Skin Disease in Cutaneous Lupus Erythematosus25. The Musculoskeletal System and Bone Metabolism
26. Pathogenesis and Treatment of Atherosclerosis in Lupus27. Cardiopulmonary Disease in SLE
28. Pathogenesis of the Nervous System29. Clinical Aspects of the Nervous System
30. Psychopathology, Neurodiagnostic Testing, and Imaging31. Ocular, Aural, and Oral Manifestations
32. Management of Sjögren Syndrome in Patients with SLE33. Gastrointestinal and Hepatic Manifestations
34. Hematologic and Lymphoid Abnormalities in SLE35. Clinical and Epidemiologic Features of Lupus Nephritis
Section V: The Reproductive System & Hormones
36. Pregnancy in Women with SLE
37. Neonatal Lupus Erythematosus38. Reproductive and Hormonal Issues in Women with Autoimmune Diseases
Section VI: Special Considerations, Subsets of SLE and Lupus-Related Syndromes
39. Drug-Induced Lupus: Etiology, Pathogenesis, and Clinical Aspects
40. SLE in Childhood and Adolescence41. Mixed Connective Tissue Disease and Undifferentiated Connective Tissue Disease
42. Clinical Aspects of the Antiphospholipid SyndromeSection VII: Assessment of Lupus43. Clinical Application of Serologic Tests, Serum Protein Abnormalities, and Other Clinical Laboratory Tests in SLE
44. Differential Diagnosis and Disease Associations
45. SLE and Infections46. Clinical Measures, Metrics and Indices
Section VIII: Management of SLE
47. Principles of Therapy, Local Measures, Nonsteroidal Medications
48. Systemic Glucocorticoid Therapy in SLE49. Antimalarial Medications
50. Immunosuppressive Drug Therapy51. Specialized Treatment Approaches and Niche Therapies for Lupus Subsets
52. Adjunctive and Preventive Measures53. Novel Therapies for SLE: Biological Agents Available in Practice Today
54. Critical Issues in Drug Development for SLE55. Socioeconomic and Disability Aspects
Section IX: Outcomes and Future Considerations
56. Investigational Agents and Future Therapy for SLE
57. Mortality in SLEAppendix: Lupus Resource Materials
Index
